The life sciences industry is drowning beneath a sea of new
regulations and directives. As well as being immensely demanding
from a risk management perspective, the associated administration
is detracting from core activities. Even basic administrative tasks,
such as checking updates to labelling, consume hours of PhDqualified
staff time – capacity firms cannot afford. This is having
an effect on professionals’ morale. Organisations should take heed,
or risk losing valued experts at a time when experienced regulatory
and QA personnel are in short supply, warns Dr Jutta Hohenhörst
of Schlafender Hase.
https://international-pharma.com/wp-content/uploads/2016/07/Reg-3-The-Great-Brain-Drain.pdf